Steroid sulfatase-deficient mice exhibit endophenotypes relevant to Attention Deficit Hyperactivity Disorder

Psychoneuroendocrinology

Volumn 37, Issue 2, 2012, Pages 221-229

  Trent, Simon ^a,b,c   Dennehy, Alison ^b   Richardson, Heather ^b   Ojarikre, Obah A ^d   Burgoyne, Paul S ^d   Humby, Trevor ^a,b,c   Davies, William ^a,b,c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Anxiety; Basal forebrain; COUMATE; Dehydroepiandrosterone sulfate; Locomotor activity; Neurosteroid

Indexed keywords

CORTICOSTEROID; ENZYME INHIBITOR; PRASTERONE; STEROID HORMONE; STEROID SULFATASE INHIBITOR; STERYL SULFATASE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL HOUSING; ANIMAL MODEL; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; DRINKING BEHAVIOR; EMOTIONALITY; ENDOPHENOTYPE; ENZYME DEFICIENCY; FEMALE; FOOD INTAKE; HORMONE BLOOD LEVEL; MALE; MENTAL TASK; MOUSE; NONHUMAN; OPEN FIELD TEST; PRASTERONE BLOOD LEVEL; PRIORITY JOURNAL; SOCIAL DOMINANCE; STEROID BLOOD LEVEL;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR, ANIMAL; COUMARINS; ENDOPHENOTYPES; EXPLORATORY BEHAVIOR; ICHTHYOSIS, X-LINKED; MICE; MICE, MUTANT STRAINS; SULFONAMIDES;

EID: 83555174391     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.06.006     Document Type: Article

References (54)

1. Able S.L., Johnston J.A., Adler L.A., Swindle R.W. Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol. Med. 2007, 37:97-107.
2. Baunez C., Amalric M., Robbins T.W. Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus. J. Neurosci. 2002, 22:562-568.
3. Bergvall A.H., Fahlke C., Hansen S. An animal model for type 2 alcoholism? Alcohol consumption and aggressive behavior following lesions in the raphe nuclei, medial hypothalamus, or ventral striatum-septal area. Physiol. Behav. 1996, 60:1125-1135.
4. Brookes K.J., Hawi Z., Kirley A., Barry E., Gill M., Kent L. Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:1531-1535.
5. Brookes K.J., Hawi Z., Park J., Scott S., Gill M., Kent L. Polymorphisms of the steroid sulfatase (STS) gene are associated with attention deficit hyperactivity disorder and influence brain tissue mRNA expression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:1417-1424.
6. Burgoyne P.S., Mahadevaiah S.K., Perry J., Palmer S.J., Ashworth A. The Y* rearrangement in mice: new insights into a perplexing PAR. Cytogenet. Cell Genet. 1998, 80:37-40.
7. Chiang H.L., Gau S.S., Ni H.C., Chiu Y.N., Shang C.Y., Wu Y.Y., Lin L.Y., Tai Y.M., Soong W.T. Association between symptoms and subtypes of attention-deficit hyperactivity disorder and sleep problems/disorders. J. Sleep Res. 2010, 19:535-545.
8. Cho S.C., Jung S.W., Kim B.N., Hwang J.W., Shin M.S., Kim J.W., Chungh D.S., Kim H.W. Temperament and character among Korean children and adolescents with anxiety disorders. Eur. Child Adolesc. Psychiatry 2009, 18:60-64.
9. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Erlbaum Associates, Lawrence. 2nd edition.
10. Compagnone N.A., Mellon S.H. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 2000, 21:1-56.
11. Compagnone N.A., Salido E., Shapiro L.J., Mellon S.H. Expression of steroid sulfatase during embryogenesis. Endocrinology 1997, 138:4768-4773.
12. Cormier E. Attention deficit/hyperactivity disorder: a review and update. J. Pediatr. Nurs. 2008, 23:345-357.
13. Cortese S., Bernardina B.D., Mouren M.C. Attention-deficit/hyperactivity disorder (ADHD) and binge eating. Nutr. Rev. 2007, 65:404-411.
14. Davies W., Humby T., Isles A.R., Burgoyne P.S., Wilkinson L.S. X-monosomy effects on visuospatial attention in mice: a candidate gene and implications for Turner syndrome and attention deficit hyperactivity disorder. Biol. Psychiatry 2007, 61:1351-1360.
15. Davies W., Humby T., Kong W., Otter T., Burgoyne P.S., Wilkinson L.S. Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention. Biol. Psychiatry 2009, 66:360-367.
16. Doe C.M., Relkovic D., Garfield A.S., Dalley J.W., Theobald D.E., Humby T., Wilkinson L.S., Isles A.R. Loss of the imprinted snoRNA mbii-52 leads to increased 5htr2c pre-RNA editing and altered 5HT2CR-mediated behaviour. Hum. Mol. Genet. 2009, 18:2140-2148.
17. Doherty M.J., Glass I.A., Bennett C.L., Cotter P.D., Watson N.F., Mitchell A.L., Bird T.D., Farrell D.F. An Xp; Yq translocation causing a novel contiguous gene syndrome in brothers with generalized epilepsy, ichthyosis, and attention deficits. Epilepsia 2003, 44:1529-1535.
18. Eicher E.M., Hale D.W., Hunt P.A., Lee B.K., Tucker P.K., King T.R., Eppig J.T., Washburn L.L. The mouse Y* chromosome involves a complex rearrangement, including interstitial positioning of the pseudoautosomal region. Cytogenet. Cell Genet. 1991, 57:221-230.
19. Evans E.P., Phillips R.J. Inversion heterozygosity and the origin of XO daughters of Bpa/+female mice. Nature 1975, 256:40-41.
20. Faraone S.V., Sergeant J., Gillberg C., Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2003, 2:104-113.
21. Gainetdinov R. Strengths and limitations of genetic models of ADHD. Atten. Def. Hyp. Disord. 2010, 2:21-30.
22. Holden C. Sex and the suffering brain. Science 2005, 308:1574.
23. Holmberg K., Hjern A. Bullying and attention-deficit-hyperactivity disorder in 10-year-olds in a Swedish community. Dev. Med. Child Neurol. 2008, 50:134-138.
24. Kent L., Emerton J., Bhadravathi V., Weisblatt E., Pasco G., Willatt L.R., McMahon R., Yates J.R. X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. J. Med. Genet. 2008, 45:519-524.
25. Koike H., Ibi D., Mizoguchi H., Nagai T., Nitta A., Takuma K., Nabeshima T., Yoneda Y., Yamada K. Behavioral abnormality and pharmacologic response in social isolation-reared mice. Behav. Brain Res. 2009, 202:114-121.
26. Korobova O., Lane P.W., Perry J., Palmer S., Ashworth A., Davisson M.T., Arnheim N. Patchy fur, a mouse coat mutation associated with X-Y nondisjunction, maps to the pseudoautosomal boundary region. Genomics 1998, 54:556-559.
27. Le Roy I., Mortaud S., Tordjman S., Donsez-Darcel E., Carlier M., Degrelle H., Roubertoux P.L. Genetic correlation between steroid sulfatase concentration and initiation of attack behavior in mice. Behav. Genet. 1999, 29:131-136.
28. Lindzey G., Winston H., Manosevitz M. Social dominance in inbred mouse strains. Nature 1961, 191:474-476.
29. Maayan R., Yoran-Hegesh R., Strous R., Nechmad A., Averbuch E., Weizman A., Spivak B. Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder. Neuropsychobiology 2003, 48:111-115.
30. Miczek K.A., Faccidomo S., De Almeida R.M., Bannai M., Fish E.W., Debold J.F. Escalated aggressive behavior: new pharmacotherapeutic approaches and opportunities. Ann. N. Y. Acad. Sci. 2004, 1036:336-355.
31. Milner L.C., Crabbe J.C. Three murine anxiety models: results from multiple inbred strain comparisons. Genes Brain Behav. 2008, 7:496-505.
32. Moreau P.H., Cosquer B., Jeltsch H., Cassel J.C., Mathis C. Neuroanatomical and behavioral effects of a novel version of the cholinergic immunotoxin mu p75-saporin in mice. Hippocampus 2008, 18:610-622.
33. Mortaud S., Nicolas L., Pinoteau W., Tordjman S., Carlier M., Roubertoux P.L. Brain pathways mediating the pro-aggressive effect of the steroid sulfatase (Sts) gene. Behav. Genet. 2010, 40:211-219.
34. Nicolas L.B., Pinoteau W., Papot S., Routier S., Guillaumet G., Mortaud S. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Brain Res. 2001, 922:216-222.
35. Oades R.D., Daniels R., Rascher W. Plasma neuropeptide-Y levels, monoamine metabolism, electrolyte excretion and drinking behavior in children with attention-deficit hyperactivity disorder. Psychiatry Res. 1998, 80:177-186.
36. Odorisio T., Rodriguez T.A., Evans E.P., Clarke A.R., Burgoyne P.S. The meiotic checkpoint monitoring synapsis eliminates spermatocytes via p53-independent apoptosis. Nat. Genet. 1998, 18:257-261.
37. Purper-Ouakil D., Cortese S., Wohl M., Aubron V., Orejarena S., Michel G., Asch M., Mouren M.C., Gorwood P. Temperament and character dimensions associated with clinical characteristics and treatment outcome in attention-deficit/hyperactivity disorder boys. Compr. Psychiatry 2010, 51:286-292.
38. Quinn P.O. Attention-deficit/hyperactivity disorder and its comorbidities in women and girls: an evolving picture. Curr. Psychiatry Rep. 2008, 10:419-423.
39. Ramos A. Animal models of anxiety: do I need multiple tests?. Trends Pharmacol. Sci. 2008, 29:493-498.
40. Reed M.J., Purohit A., Woo L.W., Newman S.P., Potter B.V. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr. Rev. 2005, 26:171-202.
41. Roubertoux P.L., Guillot P.V., Mortaud S., Pratte M., Jamon M., Cohen-Salmon C., Tordjman S. Attack behaviors in mice: from factorial structure to quantitative trait loci mapping. Eur. J. Pharmacol. 2005, 526:172-185.
42. Spencer T.J. ADHD and comorbidity in childhood. J. Clin. Psychiatry 2006, 67(Suppl. 8):27-31.
43. Stergiakouli E., Langley K., Williams H., Walters J., Williams N.M., Suren S., Giegling I., Wilkinson L.S., Owen M.J., O'Donovan M.C., Rujescu D., Thapar A., Davies W. Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder. Genes Brain Behav. 2011, 10:334-344.
44. Strous R.D., Spivak B., Yoran-Hegesh R., Maayan R., Averbuch E., Kotler M., Mester R., Weizman A. Analysis of neurosteroid levels in attention deficit hyperactivity disorder. Int. J. Neuropsychopharmacol. 2001, 4:259-264.
45. Thapar A., O'Donovan M., Owen M.J. The genetics of attention deficit hyperactivity disorder. Hum. Mol. Genet. 2005, R275-R282. 14 Spec No. 2.
46. Thomas N.S., Sharp A.J., Browne C.E., Skuse D., Hardie C., Dennis N.R. Xp deletions associated with autism in three females. Hum. Genet. 1999, 104:43-48.
47. Tobias E.S., Bryce G., Farmer G., Barton J., Colgan J., Morrison N., Cooke A., Tolmie J.L. Absence of learning difficulties in a hyperactive boy with a terminal Xp deletion encompassing the MRX49 locus. J. Med. Genet. 2001, 38:466-470.
48. Torres E.M., Perry T.A., Blockland A., Wilkinson L.S., Wiley R.G., Lappi D.A., Dunnet S.B. Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience 1994, 63:95-122.
49. van der Staay F.J., Bouger P., Lehmann O., Lazarus C., Cosquer B., Koenig J., Stump V., Cassel J.C. Long-term effects of immunotoxic cholinergic lesions in the septum on acquisition of the cone-field task and noncognitive measures in rats. Hippocampus 2006, 16:1061-1079.
50. Walters A.S., Silvestri R., Zucconi M., Chandrashekariah R., Konofal E. Review of the possible relationship and hypothetical links between attention deficit hyperactivity disorder (ADHD) and the simple sleep related movement disorders, parasomnias, hypersomnias, and circadian rhythm disorders. J. Clin. Sleep Med. 2008, 4:591-600.
51. Wang L.J., Hsiao C.C., Huang Y.S., Chiang Y.L., Ree S.C., Chen Y.C., Wu Y.W., Wu C.C., Shang Z.Y., Chen C.K. Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate. Psychoneuroendocrinology 2011, 10.1016/j.psyneuen.2011.02.014.
52. Wang L.J., Huang Y.S., Hsiao C.C., Chiang Y.L., Wu C.C., Shang Z.Y., Chen C.K. Salivary dehydroepiandrosterone, but not cortisol, is associated with attention deficit hyperactivity disorder. World J. Biol. Psychiatry 2011, 12:99-109.
53. Williams S.F., Herberg L.J. Motivational vs. motor effects of striatal and pallidal gabergic projections to subthalamic and entopeduncular nuclei, ventromedial thalamus, and ventral globus pallidus. Pharmacol. Biochem. Behav. 1987, 26:49-55.
54. Yadid G., Sudai E., Maayan R., Gispan I., Weizman A. The role of dehydroepiandrosterone (DHEA) in drug-seeking behavior. Neurosci. Biobehav. Rev. 2010, 35:303-314.